Radiopharm Theranostics (ASX:RAD) Total Liabilities : A$38.95 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Total Liabilities?

Radiopharm Theranostics's Total Liabilities for the quarter that ended in Dec. 2023 was A$38.95 Mil.

Radiopharm Theranostics's quarterly Total Liabilities increased from Dec. 2022 (A$21.94 Mil) to Jun. 2023 (A$29.37 Mil) and increased from Jun. 2023 (A$29.37 Mil) to Dec. 2023 (A$38.95 Mil).

Radiopharm Theranostics's annual Total Liabilities increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$20.42 Mil) and increased from Jun. 2022 (A$20.42 Mil) to Jun. 2023 (A$29.37 Mil).

Radiopharm Theranostics Total Liabilities Historical Data

The historical data trend for Radiopharm Theranostics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Total Liabilities Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Total Liabilities

20.42

29.37

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	17.63	20.42	21.94	29.37	38.95

Radiopharm Theranostics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Radiopharm Theranostics's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	13.229	+	(0	+	16.141
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	29.37

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	74.95	-	45.579
	=	29.37

Radiopharm Theranostics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12.844	+	(0	+	26.106
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	38.95

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	63.293	-	24.343
	=	38.95

Radiopharm Theranostics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines